HomeNTRA • NASDAQ
add
Natera Inc
$168.51
After Hours:(0.024%)-0.040
$168.47
Closed: Sep 12, 4:40:15 PM GMT-4 · USD · NASDAQ · Disclaimer
Previous close
$173.81
Day range
$167.59 - $172.64
Year range
$117.27 - $183.00
Market cap
23.13B USD
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 546.60M | 32.24% |
Operating expense | 456.98M | 59.18% |
Net income | -100.94M | -169.43% |
Net profit margin | -18.47 | -103.86% |
Earnings per share | -0.74 | -146.67% |
EBITDA | -100.51M | -179.30% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.02B | 14.53% |
Total assets | 1.76B | 15.83% |
Total liabilities | 510.88M | -24.92% |
Total equity | 1.25B | — |
Shares outstanding | 137.25M | — |
Price to book | 19.08 | — |
Return on assets | -15.81% | — |
Return on capital | -19.18% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -100.94M | -169.43% |
Cash from operations | 37.57M | 841.70% |
Cash from investing | -23.90M | 25.45% |
Cash from financing | 12.58M | 13.87% |
Net change in cash | 26.25M | 254.26% |
Free cash flow | 35.19M | 434.63% |
About
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Founded
Jan 1, 2004
Headquarters
Website
Employees
4,429
